110 related articles for article (PubMed ID: 24984547)
21. YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma.
Lee JH; Park KH; Park JW; Hong CS
J Investig Allergol Clin Immunol; 2012; 22(7):501-7. PubMed ID: 23397672
[TBL] [Abstract][Full Text] [Related]
22. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.
Thöm I; Andritzky B; Schuch G; Burkholder I; Edler L; Johansen JS; Bokemeyer C; Schumacher U; Laack E
Cancer; 2010 Sep; 116(17):4114-21. PubMed ID: 20564116
[TBL] [Abstract][Full Text] [Related]
23. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825
[TBL] [Abstract][Full Text] [Related]
24. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer.
Yamac D; Ozturk B; Coskun U; Tekin E; Sancak B; Yildiz R; Atalay C
Adv Ther; 2008 Aug; 25(8):801-9. PubMed ID: 18670741
[TBL] [Abstract][Full Text] [Related]
25. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease.
Kronborg G; Ostergaard C; Weis N; Nielsen H; Obel N; Pedersen SS; Price PA; Johansen JS
Scand J Infect Dis; 2002; 34(5):323-6. PubMed ID: 12069012
[TBL] [Abstract][Full Text] [Related]
26. Increased Synovial Fluid YKL-40 Levels are Linked with Symptomatic Severity in Knee Osteoarthritis Patients.
Guan J; Liu Z; Li F; Feng JS; Wang HJ; Chu JG; Song YZ; Xie L; Ding LB
Clin Lab; 2015; 61(8):991-7. PubMed ID: 26427144
[TBL] [Abstract][Full Text] [Related]
27. YKL-40 in giant cells and macrophages from patients with giant cell arteritis.
Johansen JS; Baslund B; Garbarsch C; Hansen M; Stoltenberg M; Lorenzen I; Price PA
Arthritis Rheum; 1999 Dec; 42(12):2624-30. PubMed ID: 10616010
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.
Kim SH; Das K; Noreen S; Coffman F; Hameed M
World J Surg Oncol; 2007 Feb; 5():17. PubMed ID: 17286869
[TBL] [Abstract][Full Text] [Related]
29. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
Jiang T; Huang L; Zhang S
BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
[TBL] [Abstract][Full Text] [Related]
31. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J
Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of YKL-40 increases in patients with acute myocardial infarction.
Nøjgaard C; Høst NB; Christensen IJ; Poulsen SH; Egstrup K; Price PA; Johansen JS
Coron Artery Dis; 2008 Jun; 19(4):257-63. PubMed ID: 18480670
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of the inflammatory protein YKL-40 in precancers of the breast.
Qin W; Zhu W; Schlatter L; Miick R; Loy TS; Atasoy U; Hewett JE; Sauter ER
Int J Cancer; 2007 Oct; 121(7):1536-42. PubMed ID: 17565739
[TBL] [Abstract][Full Text] [Related]
35. High YKL-40 serum concentration is correlated with prognosis of Chinese patients with breast cancer.
Wang D; Zhai B; Hu F; Liu C; Zhao J; Xu J
PLoS One; 2012; 7(12):e51127. PubMed ID: 23227243
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of LAMPs and YKL-40 tissue expression in glial tumors.
Kazakova MH; Staykov DG; Koev IG; Kitov BD; Sarafian VS
Folia Med (Plovdiv); 2014; 56(3):194-8. PubMed ID: 25434077
[TBL] [Abstract][Full Text] [Related]
37. Hysteroscopy combined dilatation and curettage, serum CA125 and CA19-9 play an important role in preserving fertility or endocrine function for early-stage endometrial cancer patients.
Ni T; Liu Y; Huang Y; Sun X; Wang J; Wang YD
Eur J Gynaecol Oncol; 2017; 38(1):49-53. PubMed ID: 29767864
[TBL] [Abstract][Full Text] [Related]
38. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease.
Vind I; Johansen JS; Price PA; Munkholm P
Scand J Gastroenterol; 2003 Jun; 38(6):599-605. PubMed ID: 12825867
[TBL] [Abstract][Full Text] [Related]
39. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.
Tschirdewahn S; Reis H; Niedworok C; Nyirady P; Szendröi A; Schmid KW; Shariat SF; Kramer G; vom Dorp F; Rübben H; Szarvas T
Urol Oncol; 2014 Jul; 32(5):663-9. PubMed ID: 24814404
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic role of circulating YKL-40 in endometrial carcinoma patients: a meta-analysis of seven related studies.
Cheng D; Sun Y; He H
Med Oncol; 2014 Dec; 31(12):326. PubMed ID: 25412935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
